These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 19421187)

  • 1. No obvious extra cardiovascular risk associated with low-dose NSAIDs.
    Moore N
    Clin Pharmacol Ther; 2009 Dec; 86(6):600-1; author reply 602-4. PubMed ID: 19421187
    [No Abstract]   [Full Text] [Related]  

  • 2. Do NSAIDs actually protect against myocardial infarction and death?
    van Beers EJ; de Groot JR; Tijssen JG
    Clin Pharmacol Ther; 2009 Dec; 86(6):601-2; author reply 602-4. PubMed ID: 19865082
    [No Abstract]   [Full Text] [Related]  

  • 3. Are myocardial infarctions and death in healthy individuals associated with the use of cyclooxygenase inhibitors?
    Renner B; Brune K
    Clin Pharmacol Ther; 2009 Dec; 86(6):599-600; author reply 602-4. PubMed ID: 19421186
    [No Abstract]   [Full Text] [Related]  

  • 4. Risk of myocardial infarction and death associated with the use of nonsteroidal anti-inflammatory drugs (NSAIDs) among healthy individuals: a nationwide cohort study.
    Fosbøl EL; Gislason GH; Jacobsen S; Folke F; Hansen ML; Schramm TK; Sørensen R; Rasmussen JN; Andersen SS; Abildstrom SZ; Traerup J; Poulsen HE; Rasmussen S; Køber L; Torp-Pedersen C
    Clin Pharmacol Ther; 2009 Feb; 85(2):190-7. PubMed ID: 18987620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Balancing the cyclooxygenase portfolio.
    Armstrong PW
    CMAJ; 2006 May; 174(11):1581-2. PubMed ID: 16717266
    [No Abstract]   [Full Text] [Related]  

  • 6. NSAIDs discontinuation and myocardial infarction.
    Salvo F; Pariente A; Noize P; Fourrier-Réglat A; Moore N
    J Thromb Haemost; 2009 Sep; 7(9):1600-1. PubMed ID: 19602131
    [No Abstract]   [Full Text] [Related]  

  • 7. Role of dose potency in the prediction of risk of myocardial infarction associated with nonsteroidal anti-inflammatory drugs in the general population.
    García Rodríguez LA; Tacconelli S; Patrignani P
    J Am Coll Cardiol; 2008 Nov; 52(20):1628-36. PubMed ID: 18992652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NSAIDS and the risk of myocardial infarction: do they help or harm?
    Bhatt DL
    Eur Heart J; 2006 Jul; 27(14):1635-6. PubMed ID: 16782714
    [No Abstract]   [Full Text] [Related]  

  • 9. NSAIDs and your heart: risky or not?
    Health News; 2003 May; 9(5):7-8. PubMed ID: 12739460
    [No Abstract]   [Full Text] [Related]  

  • 10. Which NSAID is safest for your heart? Some painkillers are less likely than others to raise your cardiovascular disease risk.
    Johns Hopkins Med Lett Health After 50; 2012 Apr; 24(2):6. PubMed ID: 22550726
    [No Abstract]   [Full Text] [Related]  

  • 11. An evidence-based review of the cardiovascular risks of nonsteroidal anti-inflammatory drugs.
    Farkouh ME; Greenberg BP
    Am J Cardiol; 2009 May; 103(9):1227-37. PubMed ID: 19406264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Non steroidal anti-inflammatory drugs (NSAIDs) - balancing gastrointestinal complications and the cardiovascular risk].
    Kandulski A; Venerito M; Malfertheiner P
    Dtsch Med Wochenschr; 2009 Aug; 134(33):1635-40; quiz 1641-4. PubMed ID: 19650027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A reply: Not without costs to prevent hundreds of NSAID-related fatal cases].
    Wollheim F
    Lakartidningen; 2000 Jul; 97(30-31):3415. PubMed ID: 11016215
    [No Abstract]   [Full Text] [Related]  

  • 14. The vexations of Vioxx.
    Sibbald B
    CMAJ; 2006 Feb; 174(4):444-5. PubMed ID: 16477046
    [No Abstract]   [Full Text] [Related]  

  • 15. Time-perspective in cardiovascular risk of NSAID use after first-time myocardial infarction.
    Olsen AM; Gislason GH; Fosbøl EL
    Curr Opin Cardiol; 2013 Nov; 28(6):683-8. PubMed ID: 24077606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cochrane Musculoskeletal Group review: acute gout. Steroids or NSAIDs? Let this overview from the Cochrane Group help you decide what's best for your patient.
    Winzenberg T; Buchbinder R
    J Fam Pract; 2009 Jul; 58(7):E1-4. PubMed ID: 19607767
    [No Abstract]   [Full Text] [Related]  

  • 17. Advice on using painkillers safely. Reduce your risk of a heart attack, stroke, or death.
    Harv Heart Lett; 2013 Apr; 23(8):4. PubMed ID: 23914391
    [No Abstract]   [Full Text] [Related]  

  • 18. Cardiovascular risks mount with certain anti-inflammatory drugs. Diclofenac is cited as the most dangerous anti-inflammatory drug.
    Heart Advis; 2010 Aug; 13(8):4. PubMed ID: 22792574
    [No Abstract]   [Full Text] [Related]  

  • 19. Risk assessment, drug approval, and liability.
    Somberg JC
    Am J Ther; 2006; 13(3):181-2. PubMed ID: 16772756
    [No Abstract]   [Full Text] [Related]  

  • 20. [U.S. Food and Drug Administration (FDA) strengthens warning that non-aspirin non steroidal anti-inflammatory drugs (NSAIDs) can cause myocardial infarctions or strokes: the dentist's perspective].
    Rosen E; Tsesis I; Vered M
    Refuat Hapeh Vehashinayim (1993); 2015 Oct; 32(4):6-10, 25. PubMed ID: 26727844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.